We spoke with three people who are living with young onset Parkinson’s disease (YOPD), also called early onset PD, which describes diagnoses received before age 50. Each interviewee brings a distinct perspective on navigating PD at an earlier stage of life, sharing the unique challenges they’ve faced, the unexpected ways PD has reshaped their identities, the […]
Paraquat is banned in 70+ countries, but still legal in the US For the Parkinson’s community, this isn’t abstract science, it’s personal reality. Studies have shown that people exposed to paraquat are more likely to develop Parkinson’s disease (PD) than those who are not exposed. And thousands of families across the U.S. have now pursued […]
Since 1961, the American Parkinson Disease Association (APDA) has supported innovative scientists working to understand Parkinson’s disease (PD), improve treatments, and move closer to a cure. In 2025, APDA-funded investigators continued to drive high-impact discoveries throughout the Parkinson’s disease landscape, advancing knowledge in protein biology, brain imaging, environmental risks, and gut health, among others. These […]
Understanding the Connections Between Parkinson’s and Depression The motor symptoms of PD include tremors, stiffness, and slowed movement, but PD can also cause many non-motor symptoms that can profoundly affect quality of life. Depression is one of the most common non-motor symptoms of Parkinson’s disease (PD) and is treatable, yet often overlooked. Sometimes, people with […]
Dr. Gilbert discusses the association of pesticides and other environmental exposures and the risk of Parkinson’s disease.
New treatments on the Horizon for Parkinson’s Two new therapies are entering the final stages of clinical trials before potential FDA approval. One is a novel dopamine-based therapy for motor symptom management, and the other is a stem cell therapy poised to replace the lost brain cells of Parkinson’s disease (PD). Together, they represent two […]
On a recent episode of APDA’s Dr. Gilbert Hosts, Dr. Gilbert spoke with Dr. Malu Gamez Tansey, the James A. Caplin, MD Chair in Alzheimer’s Disease at Indiana University School of Medicine and Director of Neuroimmunology Research Group, with expertise in the relationship between gut inflammation and Parkinson’s disease (PD). We covered a lot of ground […]
In August 2025, the American Parkinson Disease Association (APDA) welcomed Anne Hubbard as its first-ever Chief Public Policy Officer, marking a major step forward in strengthening the organization’s voice in public policy and advocacy. Anne now leads APDA’s newly created Department of Public Policy & Advocacy, where she is developing a comprehensive strategy to promote […]
We’re at a Turning Point for Parkinson’s — Your Story Can Help Move Congress The Parkinson’s disease (PD) community is currently facing both urgent challenges and real opportunities. More than 90,000 Americans are diagnosed each year, and over 1 million people are living with Parkinson’s nationwide. At the same time, new legislation, scientific progress, and […]
Announcing Bridge Funding to Alleviate Parkinson’s Research Funding Cuts The American Parkinson Disease Association (APDA) funds cutting-edge research every year, identifying the most promising researchers and projects through a meticulous evaluation process. APDA has recently gone a step further to ensure that researchers who are facing unexpected delays and even cuts in funding have a […]
Simple Email Signup v2 (Salsa replacement form)
